Articles

Blood glucose levels measured in hospitalized patients during acute illness predicted the risk of developing type 2 diabetes in the following three years…. 

BIOD-531 is a new ultra-rapid-acting insulin formulation that has been shown to work better than current therapies at treating diabetes in a mid-stage trial…. 

A randomized controlled trial indicates that a vegan diet may be beneficial in relieving diabetic nerve pain…. 

Developed by Taiwanese researchers, the device can hang on a pair of glasses and is called a "pupillometer." … 

Younger age groups may be at higher risk in developing complications, possibly due to later addition of statin medications….

Renal abnormalities may be indicated by a specific key marker in type 2 diabetes…. 

Not all saturated fatty acids are the same in relation to type 2 diabetes risk….

The US Food and Drug Administration has approved Invokamet, a fixed-dose therapy combining Invokana (canagliflozin) and metformin…. Invokana, a member of the new class of drugs known as sodium glucose co-transporter 2 (SGLT2) inhibitors, was approved in the USA as a single agent in March 2013. The thumbs-up is based …

A study involving over 180,000 people showed that patients treated with metformin can live longer than non-diabetics…. 

Control solution, used for ensuring the proper function of glucose meters, doesn’t appear to be a priority among physicians, pharmacists, or patients….